Symptomatic and virological response to antiviral therapy in hepatitis C associated with extrahepatic complications of cryoglobulimia

Digestive Diseases and Sciences

Volumn 52, Issue 9, 2007, Pages 2410-2417

  Joshi, Supriya ^a   Kuczynski, Magdalena ^a   Heathcote, E Jenny ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Cryoglobulinemia; Hepatitis C; Interferon; Pegylated; Ribavirin; Vasculitis

Indexed keywords

ALPHA2B INTERFERON; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROTEINURIA; SKIN DISEASE; STATISTICAL ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; ARTHRITIS; CRYOGLOBULINEMIA; CRYOGLOBULINS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PROTEINURIA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULITIS;

EID: 34547839695     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9355-2     Document Type: Article

References (23)

1. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Piette JC, Huraux J-M, Opolon P (1994) Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106:1291- 1300
2. Lunel F, Musset L (1998) Hepatitis C virus infection and cryoglobulinemia. J Hepatol 29:848-855
3. Kayali Z, Buckwold VE, Zimmerman B, Schmidt W (2002) Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 36:978-985
4. Tavoni A, Mosca M, Ferri C, Moriconi L, La Civita L, Lombardini F, Bombardieri S (1995) Guidelines for the management of essential mixed cryoglobulinemia. Clin Exp Rheumatol 13(Suppl):191S-195S
5. Ferri C, Moriconi L, Gremignai G, Migliorini P, Paleologo G, Fosella PV, Pasero G (1986) Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange. Nephron 43:246-253
6. Abu-Shakra M, Hausmann MJ, Kachko L, Flusser D, Buskila D, Sukenik S (1998) Cyclophosphamide therapy in a patient with membranoproliferative glomerulonephritis and essential mixed cryoglobulinaemia. Clin Rheumatol 17:395-396
7. Bonomo L, Casato M, Afeltra A, Caccavo D (1987) Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 83:726-728
8. Durand JM, Cacoub P, Lunel-Fabiani F, Cosserat J, Cretel E, Kaplanski G, Frances C, Bletry O, Soubeyrand J, Godeau P (1998) Ribavirin in hepatitis C related cryoglobulinemia. J Rheumatol 25:1115-1117
9. Calleja JL, Albillos A, Moreno-Otero R, Rossi I, Cacho G, Domper F, Yebra M, Escartin P (1999) Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinemia. Aliment Pharmacol 13:1179-1186
10. Donada C, Crucitti A, Donadon V, Chemello L, Alberti A (1998) Interferon alpha and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia. Blood 92:2983-2984
11. Zuckerman E, Keren D, Slobodin G, Rosner I, Rozenbaum M, Toubi E, Sabo E, Tsykounov I, Naschitz JE, Yeshurun D (2000) Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 27:2172-2178
12. Mazzaro C, Zorat F, Caizzi M, Donada C, Di Gennaro G, Maso LD, Carniello G, Virgolini L, Tirelli U, Pozzato G (2005) Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J Hepatol 42:632-638
13. Musset L, Diemert MC, Taibi F, Thi Huong Du L, Cacoub P, Leger JM, Boissy G, Gaillard O, Galli J (1992) Characterization of cryoglobulins by immunoblotting. Clin Chem 38:798-802
14. Naarendorp M, Kallecmuchikkal U, Nuovo GJ, Gorevic PD (2001) Long-term efficacy of interferon alpha for extrahepatic disease associated with hepatitis C infection. J Rheumatol 28:2466-2473
15. Blatt LM, Mutchnick MG, Tong MJ, Klion FM, Lebovics E, Freilich B, Bach N, Smith C, Herrera J, Tobias H, Conrad A, Schmid P, McHutchison JG (2000) Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat 7:196-202
16. Cresta P, Musset L, Cacoub P, Frangeul L, Vitour D, Poynard T, Opolon P, Nguyen DT, Golliot F, Piette JC, Huraux JM, Lunel F (1999) Response to interferon alpha treatment and disappearance of cryoglobulinemia in patients infected by hepatitis C virus. Gut 45:122-128
17. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized control. Lancet 358:958-965
18. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347:975-982
19. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC (2003) Interferon alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 46:3317-3326
20. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J (1998) Randomised trial of interferon alpha 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic hepatitis C. Lancet 352:1426-1432
21. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK (1998) Interferon alpha 2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 339:1485-1492
22. Sanchez-Tapias JM, Escartin P, Enriquez J, Moreno R, Romero-Gomez M, Barcena R, Crespo J, Andrade R, Perez R, Suarez MJ, Planas R, Sola R, Garcia-Bengoechea M, Garcia-Samaniego J, Berenguer J, Berenguer J, Montoro M, Del Olmo J, Lopez G, Tome S, Casanovas T, Castellanos G, Castro A (2004) Longer treatment duration with peginterferon alfa-2a (40KD) (PEGASYS) and ribavirin (COPEGUS) in naïve patients with chronic hepatitis C and detectable HCV RNA by week 4 of therapy: final results of the randomized, multicenter TERAVIC-4 study. Hepatol 40: 218A
23. Cacoub P, Saadoun D, Limal N, Sene D, Lidove O, Piette JC (2005) PEGylated Interferon alfa-2b and ribavirin treatment in patients with hepatitis c virus-related systemic vasculitis. Arthritis Rheum 42:911-915